Bortezomib for the treatment of multiple myeloma
Editorial Group: Cochrane Haematological Malignancies Group
Published Online: 11 NOV 2013
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Scott K, Hayden PJ, Howman A, Wheatley K, Coyne I. Bortezomib for the treatment of multiple myeloma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010816. DOI: 10.1002/14651858.CD010816.
- Publication Status: New
- Published Online: 11 NOV 2013
This is the protocol for a review and there is no abstract. The objectives are as follows:
We will assess the effects of bortezomib treatment in comparison to other therapies, different doses, treatment administration and schedules of bortezomib, on overall survival (OS), progression-free survival (PFS), response rate (RR), health-related quality of life (HRQoL), adverse events (AE) and treatment-related death.